Groove pancreatitis has a spectrum of severity and can be managed conservatively.


Journal

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
ISSN: 1424-3911
Titre abrégé: Pancreatology
Pays: Switzerland
ID NLM: 100966936

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 30 04 2020
revised: 22 11 2020
accepted: 26 11 2020
pubmed: 15 12 2020
medline: 1 5 2022
entrez: 14 12 2020
Statut: ppublish

Résumé

The natural history of groove pancreatitis is incompletely characterized. Published literature suggests a high rate of surgery. We describe the short- and long-term outcomes in a cohort of patients with groove pancreatitis treated at our institution. Medical records of patients hospitalized in the University of Pittsburgh Medical Center system from 2000 to 2014 and diagnosed with groove pancreatitis based on imaging were retrospectively reviewed. Clinical presentation and outcomes during index admission and follow-up were recorded. Forty-eight patients with groove pancreatitis were identified (mean age 53.2 years, 79% male). Seventy-one percent were alcohol abusers and an equal number were cigarette smokers. Prior histories of acute and chronic pancreatitis were noted in 30 (62.5%) and 21 (43.8%), respectively. Forty-four (91.7%) met criteria for acute pancreatitis during their index admission. Alcohol was the most common etiology (68.8%). No patient experienced organ failure. The most frequent imaging findings were fat stranding in the groove (83.3%), duodenal wall thickening (52.1%), and soft tissue mass/thickening in the groove (50%). Over a mean follow-up of 5.0 years, seven (14.6%) required a pancreas-related surgery. Patients had a high burden of pancreatitis-related readmissions (68.8%, 69.4/100 patient-years). Incident diabetes and chronic pancreatitis were diagnosed in 5 (13.9% of patients at risk) and 8 (29.6% of patients at risk) respectively. Groove pancreatitis has a wide spectrum of severity; most patients have mild disease. These patients have a high burden of readmissions and progression to chronic pancreatitis. A small minority requires surgical intervention.

Sections du résumé

BACKGROUND & AIMS OBJECTIVE
The natural history of groove pancreatitis is incompletely characterized. Published literature suggests a high rate of surgery. We describe the short- and long-term outcomes in a cohort of patients with groove pancreatitis treated at our institution.
METHODS METHODS
Medical records of patients hospitalized in the University of Pittsburgh Medical Center system from 2000 to 2014 and diagnosed with groove pancreatitis based on imaging were retrospectively reviewed. Clinical presentation and outcomes during index admission and follow-up were recorded.
RESULTS RESULTS
Forty-eight patients with groove pancreatitis were identified (mean age 53.2 years, 79% male). Seventy-one percent were alcohol abusers and an equal number were cigarette smokers. Prior histories of acute and chronic pancreatitis were noted in 30 (62.5%) and 21 (43.8%), respectively. Forty-four (91.7%) met criteria for acute pancreatitis during their index admission. Alcohol was the most common etiology (68.8%). No patient experienced organ failure. The most frequent imaging findings were fat stranding in the groove (83.3%), duodenal wall thickening (52.1%), and soft tissue mass/thickening in the groove (50%). Over a mean follow-up of 5.0 years, seven (14.6%) required a pancreas-related surgery. Patients had a high burden of pancreatitis-related readmissions (68.8%, 69.4/100 patient-years). Incident diabetes and chronic pancreatitis were diagnosed in 5 (13.9% of patients at risk) and 8 (29.6% of patients at risk) respectively.
CONCLUSIONS CONCLUSIONS
Groove pancreatitis has a wide spectrum of severity; most patients have mild disease. These patients have a high burden of readmissions and progression to chronic pancreatitis. A small minority requires surgical intervention.

Identifiants

pubmed: 33309222
pii: S1424-3903(20)30851-6
doi: 10.1016/j.pan.2020.11.018
pmc: PMC9078205
mid: NIHMS1803049
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

81-88

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK077906
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK108306
Pays : United States

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The other authors declare no conflict.

Références

Am J Gastroenterol. 2015 Nov;110(11):1598-606
pubmed: 26372506
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
Gut. 1993 Mar;34(3):343-7
pubmed: 8097180
J Gastroenterol. 1998 Apr;33(2):289-94
pubmed: 9605965
Pancreas. 2005 May;30(4):e92-5
pubmed: 15841034
Am J Surg. 1992 Mar;163(3):312-6; discussion 317-8
pubmed: 1539765
Gastroenterology. 2012 Jun;142(7):1476-82; quiz e15-6
pubmed: 22425589
Pancreas. 2014 Nov;43(8):1143-62
pubmed: 25333398
Endoscopy. 2014 Jul;46(7):580-7
pubmed: 24839187
AJR Am J Roentgenol. 2013 Jul;201(1):W29-39
pubmed: 23789694
Dig Surg. 2010;27(2):149-52
pubmed: 20551662
Semin Diagn Pathol. 2004 Nov;21(4):247-54
pubmed: 16273943
Neth J Med. 2013 Mar;71(2):104
pubmed: 23462062
Gastroenterology. 2015 Nov;149(6):1490-1500.e1
pubmed: 26299411
Cir Esp. 2016 Jun-Jul;94(6):346-52
pubmed: 27048910
Pancreatology. 2017 Jan - Feb;17(1):32-40
pubmed: 28341116
Am J Gastroenterol. 2007 Apr;102(4):871-9
pubmed: 17324133
Pancreas. 2015 Aug;44(6):901-8
pubmed: 25899649
Pancreas. 2016 Jan;45(1):e14-5
pubmed: 26658044
Gut. 1984 Jul;25(7):756-9
pubmed: 6735257
Biomed Res Int. 2014;2014:185265
pubmed: 24995273
Gastrointest Endosc. 2005 Jan;61(1):175-8
pubmed: 15672084
Clin Gastroenterol Hepatol. 2014 Nov;12(11):1911-9
pubmed: 24815327
Abdom Radiol (NY). 2020 May;45(5):1439-1446
pubmed: 31559471
Pancreas. 2017 Apr;46(4):489-495
pubmed: 28196024
Int J Pancreatol. 1991 Nov-Dec;10(3-4):173-82
pubmed: 1787332
Clin Gastroenterol Hepatol. 2014 Feb;12(2):311-6
pubmed: 23958561
Hepatogastroenterology. 1982 Oct;29(5):198-208
pubmed: 7173808
Am J Surg Pathol. 2017 Oct;41(10):1347-1363
pubmed: 28795998

Auteurs

Kohtaro Ooka (K)

New York University, Division of Gastroenterology and Hepatology, USA. Electronic address: kohook1@gmail.com.

Harkirat Singh (H)

University of Pittsburgh, Division of Gastroenterology, Hepatology and Nutrition, USA. Electronic address: singhh3@upmc.edu.

Matthew G Warndorf (MG)

Albany Gastroenterology Consultants, USA. Electronic address: mwarndorf@gmail.com.

Melissa Saul (M)

Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: mis18@pitt.edu.

Andrew D Althouse (AD)

University of Pittsburgh, Center for Research on Health Care Data Center, USA. Electronic address: ada62@pitt.edu.

Anil K Dasyam (AK)

University of Pittsburgh, Department of Radiology, USA. Electronic address: dasyamak@upmc.edu.

Pedram Paragomi (P)

University of Pittsburgh, Division of Gastroenterology, Hepatology and Nutrition, USA. Electronic address: pedram.paragomi@gmail.com.

Anna Evans Phillips (AE)

University of Pittsburgh, Division of Gastroenterology, Hepatology and Nutrition, USA. Electronic address: evansac3@upmc.edu.

Amer H Zureikat (AH)

University of Pittsburgh, Division of Surgical Oncology, USA. Electronic address: zureikatah@upmc.edu.

Kenneth K Lee (KK)

University of Pittsburgh, Division of Surgical Oncology, USA. Electronic address: leek@upmc.edu.

Adam Slivka (A)

University of Pittsburgh, Division of Gastroenterology, Hepatology and Nutrition, USA. Electronic address: slivkaa@upmc.edu.

Georgios I Papachristou (GI)

Ohio State University Wexner Medical Center, Division of Gastroenterology, Hepatology and Nutrition, USA. Electronic address: georgios.papachristou@osumc.edu.

Dhiraj Yadav (D)

University of Pittsburgh, Division of Gastroenterology, Hepatology and Nutrition, USA. Electronic address: yadavd@upmc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH